JPRN-UMIN000042922已完成未知
Influence investigation by the pharmacist follow after the medication - Influence investigation by the pharmacist follow after the medication
others Chiba Pharmaceutical Association0 个研究点目标入组 37 人开始时间: 2021年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patient who receives visit drug management instruction The patient who cannot list the VAS method by a physical reason The patient who does not have legal representative
研究者
相似试验
已完成
不适用
An observational study to determine the pharmacokinetics of pemetrexed with and without hyperhydration during cisplatin administration (HYDRA).10038666NSCLClung cancerNL-OMON44619Jeroen Bosch Ziekenhuis15
招募中
不适用
The influence of hyperhydration on pemetrexed concetrations in blood.NL-OMON21433ZANOB pharmacy/Jeroen Bosch Hospital15
尚未招募
1 期
The role of pharmacist for enhancing medication adherence in COPD (Chronic Obstructive Pulmonary Diseases) patients in pakistaChronic Obstructive Pulmonary Disease (COPD).Chronic obstructive pulmonary disease, unspecifiedJ44.9IRCT20220516054875N1Quaid-i-Azam University , Islamabad150
招募中
不适用
This study is being conducted to evaluate the safety and efficacy of a strategy of early fibrinolytic treatment with Reteplase (rPA) in patients with ST- segment elevation myocardial infarction (STEMI).CTRI/2017/09/009796STEMI INDIA200
进行中（未招募）
1 期
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant PatientsRenal TransplantationMedDRA version: 19.0Level: LLTClassification code 10023438Term: Kidney transplantSystem Organ Class: 100000004865EUCTR2016-001042-25-Outside-EU/EEAF. Hoffmann-La Roche AG720